Ovarian Cancer Australia welcomes the recent change in national clinical genetic testing guidelines for women with ovarian cancer.
eviQ is an Australian government online resource of evidence based cancer treatment protocols and information that is developed by multidisciplinary teams of cancer specialists. Following a successful submission by Ovarian Cancer Australia, eivQ now recommends that all women with certain subtypes of ovarian cancer regardless of age of diagnosis have their BRCA1 and BRCA2 genes tested.
Previously, women diagnosed over 70 needed to meet certain other criteria such as family history of specific types of cancer, small family size or have recurrent disease and need genetic testing for eligibility for Olaparib.
Frequently Asked Questions (FAQ)
Clinical genetic testing of BRCA1 and BRCA2 genes is now recommended for all women diagnosed with high grade epithelial ovarian cancer (except mucinous subtype).
How is this different to the previous protocol?
Previously genetic testing of BRCA1 and BRCA2 genes for women with certain subtypes of ovarian cancer was recommended if diagnosed under the age of 70. For women diagnosed over 70 access depended on family history of cancer, number of relatives, whether or not disease had reoccurred etc.
I have been diagnosed with ovarian cancer and have not had clinical genetic testing. How do I know if I am eligible?
The type of ovarian cancer determines eligibility. If you were diagnosed with high grade epithelial ovarian cancer such as the ‘serous’, ‘endometrioid’ or ‘clear cell’ subtypes or some other rarer types you can access genetic testing. (note ‘mucinous’ subtype is not eligible)
Why is genetic testing of BRCA1 and BRCA2 genes only available for certain types of ovarian cancer?
These genes are not associated with all types of ovarian cancer or ovarian tumours. For some types of ovarian cancer the chance of finding a gene fault is no higher than in the general population.
Why should I consider genetic testing?
Genetic testing can determine if you and your relatives are at increased risk of developing certain types of cancer. It may also help your doctors determine treatment options for your ovarian cancer. If a gene fault is found you relatives can have testing to help make decsions about cancer screening and cancer prevention options.
Want to know more?
Ovarian Cancer Australia is collaborating in a project called TRACEBACK. The aim of TRACEBACK is to help women living with ovarian cancer access clinical genetic testing. Please talk to you doctor or call TRACEBACK on 1800 955 011 if you have queries about genetic testing.
Ovarian Cancer Australia's Support Team are also here to answer any questions you may have. Contact our Helpline on 1300 660 334 or email email@example.com